This application relates to the differentiation and identification of analogous chemical and biological substances with RFID biosensors.
Parent U.S. application Ser. No. 11/088,809 describes and claims a biosensor detection system for detecting a particular substance, said system having at least two biosensor devices, each biosensor device including a piezoelectric material, an input transducer mounted on the piezoelectric material to receive an input radio frequency signal and generate a corresponding acoustic wave within the piezoelectric material, an output transducer mounted on the piezoelectric material to receive the acoustic wave and transmit a corresponding output radio frequency signal, a biolayer mounted on the piezoelectric material to receive a substance to be tested and cause a corresponding change in the acoustic wave, and an oscillator circuit connected to the input transducer and to the output transducer, said oscillator circuit including an amplifier and providing an output signal indicative of a change in the acoustic wave, the biosensor devices having two different biolayers which are chemically orthogonal or semi-orthogonal to each other, whereby the output signals can be utilized to detect receipt of a particular substance by the biolayers of the biosensor devices.
The present invention provides acoustic wave (AW) radio frequency identification device (RFID) biosensors configured with chemically orthogonal or semi-orthogonal biolayers and a processing system which are capable of detecting differentiating and identifying analogous chemical and biological substances.
According to one aspect of the invention, an RFID biosensor detection system for detecting particular substances has an interrogator circuit to transmit a radio frequency signal, a piezoelectric material, an input transducer mounted on the piezoelectric material to receive an input radio frequency signal and propagate a corresponding acoustic wave within the piezoelectric material, at least two chemically orthogonal or semi-orthogonal biolayers mounted on the piezoelectric material to receive substances to be tested and cause corresponding changes in the acoustic wave an output transducer mounted on the piezoelectric material to receive the acoustic wave and transmit a corresponding output radio frequency signal, and a receiver circuit to receive the corresponding output radio frequency signal and provide separate channel data indicative of the substances received.
Classification of similar molecules in accordance with the present invention is based on the concept of the RFID biosensor having both the ability to detect using multiple chemically orthogonal or semi-orthogonal biolayers and to return back to a processing system an interrogation signal which has been suitably modified to contain multi-dimensional information. The processing system can then separate out the return signal and process the information to provide a multi-dimensional state-space map.
Embodiments of the invention will now be described, by way of example, with reference to the accompanying drawings, of which:
a) shows the dual track RFID biosensor signals,
b) shows a dual track RFID biosensor receiver,
a) shows RFID biosensor and multiple reflector array signals,
b) shows an RFID biosensor and multiple reflector array receiver,
a) is a graph showing a five-bit Barker code correlation as a function of biolayer X,
b) is a graph showing a five-bit Barker code correlation as a function of biolayer Y, and
Referring to the drawings, a multi-dimensional RFID biosensor and processing system 100 is shown in
The sequence of detection for the multi-dimensional RFID biosensor and processing system 100 begins when a processing system 140 initiates, via an interrogator and receiver system 150, a signal 130 of suitable strength via an antenna 135 to stimulate the AW RFID 120. The electrical signal 130 is conveyed via the AW RFID antenna 123 to the AW RFID IDT 121 and converted to appropriate acoustic waves. The acoustic waves interact with the (X) channel detector 125, the (Y) channel detector 127 and continuing up to and including the (n) channel detector 129. The acoustic waves are modified only if the (X) channel detector 125 has detected any analogous (X) substances or, similarly, if the (Y) channel detector 127 has detected any analogous (Y) substances, and, similarly, if a channel detector continuing up to and including the (n) channel detector 129 has detected any analogous substances. The acoustic waves will be modified in accordance with the following equation (1) which was published in W. D. Hunt et al., “Time-dependent signatures of acoustic wave biosensors,” IEEE Proceedings, Vol. 91, no. 6, pp. 890-901, June 2003;
where Vs is the acoustic velocity, ρ is the density of the film, hf is the thickness of the film, μq and ρq are the shear stiffness and density of the quartz crystal respectively, μ is the stiffness of the film, and Δ is the difference between perturbed and unperturbed (denoted by subscript u) quantities. The stiffness of the film, μ, is affected by the conformational change of the recognition molecules.
The result is that the AW RFID 120 now has generated acoustic waves with detection information pertaining to the (X) channel detector 125, the (Y) channel detector 127 and continuing up to and including the (n) channel detector 129. The AW RFID IDT 121 now combines and converts these acoustic waves to electrical signals which are conveyed via the AW RFID antenna 123 as a signal 130 returning to the processing system 140 and into the interrogator and receiver 150 via a system antenna 135. The interrogator and receiver 150 receive these modified signals and processes them within a channel separation step 160 where the combined detection information from each of the (X) channel detector 125, the (Y) channel detector 127 and continuing up to and including the (n) channel detector 129 is separated out and stored within a (X) location, a (Y) location and continuing up to and including the (nth) location. Finally, the data from these stored locations is mapped using state-space mapping 170. The final result is that each detected analogous substance is projected onto a multi-dimensional state-space map.
The main advantages of detecting, differentiating and identifying analogous chemical and biological substances using RFID biosensor type devices in accordance with the present invention:
Various RFID biosensor structures in accordance with the invention can be fashioned to incorporate multiple chemically orthogonal or semi-orthogonal biolayers and produce signals which have the means and capacity to contain detected data from the multiple chemically orthogonal or semi-orthogonal biolayers, as will now be described. Receiver structures will also be described to illustrate how data from each channel can be separated out to distinguish X, Y and up to n data sets to formulate a multi-dimensional state-space map.
Dual Track RFID Biosensor
A schematic view of a dual track RFID biosensor configuration 200 is shown in
The dual track RFID biosensor configuration 200 is shown with a split finger design, with both the width and spacing of the fingers being one-eighth of an acoustic wavelength. The dual track RFID biosensor configuration 200 can equally function with a typical quarter-wavelength design where both the width and spacing of the fingers are one-quarter of an acoustic wavelength. The key to this dual track configuration is the phase of offset of 90° or one-quarter of an acoustic wavelength between the track X IDT 230 and the track Y IDT 235. This offset will produce a returned interrogation signal similar to the dual track RFID biosensor signal 300 shown in
The dual track RFID biosensor receiver 310 shown in
RFID Biosensor with Multiple Reflector Arrays
Reflector array X 430 has in its proximity a chemically orthogonal or semi-orthogonal biolayer X 435 where, if substances which are analogous to biolayer X 435 reach the receptor sites within biolayer X 435, a perturbation of the acoustic waves specific to those which interact with reflector array X 430 will cause a modification of the characteristics of the reflected acoustic wave being propagated back to the input/output IDT 410. Similarly, reflector array Y 440 has in its proximity a chemically orthogonal or semi-orthogonal biolayer Y 445 where, if substances which are analogous to biolayer Y 445 reach the receptor sites within biolayer Y 445, a perturbation of the acoustic waves specific to those which interact with reflector Y 440 will cause a modification of the characteristics of the reflected acoustic wave being propagated back to the input/output IDT 410. These collections of reflected acoustic waves from reflector arrays 420, 430 and 440 converge at separate times at the input/output IDT 410 and are converted to equivalent electrical signals which propagate back to the processing system 140 via the antenna 405.
Such RFID biosensors with multiple reflector array signals 500 are shown in
An RFID biosensor multiple reflector array receiver 520 is shown in
The RFID biosensor with multiple reflector arrays 400, the RFID biosensor with multiple reflector array signals 500 and the RFID biosensor with multiple reflector array receiver 520 can be extended to an n-dimensional system capable of producing n-dimensional state-space mapping for analogous substances, as will now be readily apparent to a person skilled in the art.
RFID Biosensors With Correlation Based Detection Schemes
A useful feature which is inherent in AW RFID biosensors is the ability to encode the interdigital transducers such that the encoding process of the AW RFID device expands the data over a specific frequency range and that, within the receiver, a reference compressor then correlates the data to produce a correlation function which is time based and convenient for extraction of certain information. Any deviation of the signals within the AW RFID biosensor expander will then alter the peak and sidelobes of the final correlation function when using a reference compressor which remains constant. These encoding methods have previously been described in U.S. Pat. No. 7,053,524 (Edmonson et al.) issued May 30, 2006, with a more detailed description of the correlation functions being found in P. J. Edmonson, “SAW pulse compression using combined Barker codes, Masters Thesis in Electrical Engineering, McMaster University, Hamilton, Ontario, 124 pages, March 1989.
A 5-bit bi-phase Barker coded RFID biosensor with multiple chemically orthogonal or semi-orthogonal biolayers 600 is shown in
The geometric positioning of the fingers, which dictates the polarity of the IDTs is important for bi-phase coded structures. In this embodiment, each bit is made up of two finger pairs, with each finger pair being made up of oppositely positioned fingers. The finger pairs are continuous for Bit # 1631, Bit #2632 and Bit #3633 but are interchanged during the transition from Bit #3633 to Bit #4634 and during the transition from Bit #4634 to Bit #5635. This sequence of finger geometry now represents the 5-bit bi-phase Barker code of 1, 1, 1, −1, 1 where there is a 180° phase transition between the third and fourth and fourth and fifth bits. Also, in this embodiment, chemically orthogonal or semi-orthogonal biolayer X 650 is positioned within the finger structure of Bit #2632, and chemically orthogonal or semi-orthogonal biolayer Y 655 is positioned within the finger structure of Bit #4634.
The correlation function can be derived by using signal processing techniques on the coded electrical signal which is transmitted back out from the antenna 610 to the processing system 140. This signal processing technique comprises a series of time inversion multiplications, shifting and summing between the returned coded signal (expander) and a reference code (compressor). The following Table 1 illustrates this correlation process for a 5-bit bi-phase Barker code of sequence (1, 1, 1, −1, 1).
In row #1, the time reversed code is placed within each bit being multiplied by the first bit of the Barker sequence, which in this example is a “1”. Similarly, in row #2, the time reversed code is shifted by one bit period and multiplied by the second bit of the Barker sequence, which in this example is a “1”. For row #3, the time reversed code is again shifted by one bit period and multiplied by the third bit of the Barker sequence, which in this example is a “1”. For row #4, the time reversed code is again shifted by one bit period and multiplied by the fourth bit of the Barker sequence, which in this example is a “−1” and for row #5, the time reversed code is again shifted by one bit period and multiplied by the fifth bit of the Barker sequence, which in this example is a “1”. Row #7 is the sum of the bits positioned in the columns directly above each value. The resulting correlation function is then, 1, 0, 1, 0, 5, 0, 1, 0, 1.
Perturbations within the area of the biolayers will change the correlation function. The changes are both distinguishable and distinct to each separately placed biolayer. Such perturbations are caused due to substances which are analogous to biolayer X 650 interacting with the receptor sites within biolayer X 650 to produce a perturbation of the acoustic waves specific to those which interact with bit #2632. Similarly, perturbations which are caused due to substances that are analogous to biolayer Y 655 interacting with the receptor sites within biolayer Y 655 produce a perturbation of the acoustic waves specific to those which interact with bit #4634.
The following Table 2 illustrates a correlation process for a 5-bit bi-phase Barker code of sequence (1, 0.75, 1, −1, 1) when the second bit is first perturbed, for this embodiment from a value of “1” to a value of “0.75”. This perturbation would be the result of a change within the biolayer X 650 which is positioned in proximity to Bit #2632.
One of the distinct features of this perturbed correlation function is that the changes occur near the middle and to the right hand side of the correlation function.
The following Table 3 illustrates a correlation process for a 5-bit bi-phase Barker code of sequence (1, 1, 1, −0.75, 1) when the fourth bit is perturbed, in this example from a value of “−1” to a value of “−0.75”. This perturbation would be the result of a change within the biolayer Y 655 which is positioned in proximity to Bit #4634.
One of the distinct features of Table 3 is that the perturbed correlation function changes occur near the middle and to the left hand side of the correlation function, which is opposite to that of Table 2.
A comparison of a 5-bit Barker code correlation as a function of biolayer X 700 is shown in
An RFID biosensor correlation receiver 800 is shown in
The above example describing a 5-bit bi-phase Barker coded RFID biosensor with multiple chemically orthogonal or semi-orthogonal biolayers 600, the correlation as a function of biolayer X 700, the correlation as a function of biolayer Y 750 and an RFID biosensor correlation receiver 800 can be extended by those skilled in the art to an n-dimensional chemically orthogonal or semi-orthogonal system capable of producing n-dimensional state-space mapping.
The previously described three methods of utilizing AW RFID biosensors to detect, differentiate and identify analogous chemical and biological substances are not limited to only the two-dimensional X and Y data for the construction of a state-space map, but can be expanded by those skilled in the art to n-dimensional configurations. One technique to include several chemically orthogonal and semi-orthogonal biolayers would be to combine the structures of the dual track RFID biosensor configuration 200 (
Other embodiments and advantages of the invention will now be readily apparent to a person skilled in the art, the scope of the invention being defined in the appended claims.
This application is a continuation-in-part of U.S. patent application Ser. No. 11/088,809 filed Mar. 25, 2005, the contents of which are hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4361026 | Muller et al. | Nov 1982 | A |
5571568 | Ribi et al. | Nov 1996 | A |
7451649 | Edmonson et al. | Nov 2008 | B2 |
Number | Date | Country | |
---|---|---|---|
20080127729 A1 | Jun 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11088809 | Mar 2005 | US |
Child | 11976345 | US |